A phase I study to evaluate the safety, tolerability, and pharmacokinetics of EIS-10700 in healthy volunteers
Latest Information Update: 13 Nov 2023
At a glance
- Drugs EIS 10700 (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions; First in man
Most Recent Events
- 13 Nov 2023 New trial record